Life sciences briefing: Monday, Jan. 7, 2008
TODAY’S HEADLINES:
Surgical-device maker Aragon Surgical receives $25M (release)
Tacere Therapeutics strikes RNAi deal with Pfizer for up to $145M (release)
Benvenue Medical raises $15M for spine-repair devices (release)
Genome-association co. Genizon BioSciences draws C$31M (release)
Contract research organization Inclinix pulls in $10M (release)
EPocrates, healthcare IT developer, gets strategic investment from Goldman Sachs (release)
ZyGem closes first funding round (release)
Onset Ventures names John Ryan partner (release)
Retired Scripps immunologist Richard Ulevitch joins 5AM Ventures (release)
SV Life Sciences promotes Darren Black to partner… Continue Reading
Tacere Therapeutics sells equity stake to Oncolys BioPharma for hepatitis-drug development
Tacere Therapeutics, a San Jose, Calif., biotech developing new RNA-based drugs, struck a partnership with Tokyo’s Oncolys BioPharma to co-develop a treatment for hepatitis C. The companies didn’t disclose financial terms of the deal.
In exchange for an undisclosed equity investment in Tacere, Oncolys will hold an option to acquire Asian rights to Tacere’s drug TT-033, which Tacere hopes to move into clinical trials late next year.
TT-033 is a drug based on a new and… Continue Reading